Login to South West London Pathology Services

If you have any queries about pathology consumables – you need a new account or you have a query about your order, please telephone 020 8266 6827. Forgotten your password

Blood borne pathogens

Why is screening for blood borne pathogens important?

Blood borne pathogens, including the viruses(BBVs) like hepatitis B, hepatitis C, HIV and syphilis, are a serious public health concern because they are readily transmitted during sexual intercourse, sharps injury or needle sharing.

The early stages of infection are often silent and during this period, transmission to others can take place unknowingly. With effective treatments now available for syphilis and other blood borne viruses, these pathogens can be controlled and patients cured.

Diagnostic tests that allow accurate and prompt detection and effective clearance of these pathogens are essential contributors to patient management, patient wellbeing, and public safety. However, not all patients are aware that they are carriers.

Community interventions that do not need appointments at GP or hospital clinics require community solutions to screening populations at risk, eg at pharmacists and drug and alcohol centres, prison screening programmes, HIV at-risk population screening and hepatitis C eradication programmes. For these to succeed, novel approaches to blood screening without the need for phlebotomy services are crucial.

Blood borne pathogen testing at South West London Pathology

South West London Pathology (SWLP) has developed an innovative solution to blood borne pathogen screening using capillary blood testing. Capillary blood testing involves taking a small blood sample (approximately eight drops of capillary blood) from a puncture on the finger using a safety lancet and processing this sample with dilution techniques, without altering test sensitivity and specificity.

It is particularly useful for those patients who are difficult to bleed (including babies and infants) and in the home testing setting. . The patient or an assistant lances a finger-tip and collects 250 µL of capillary blood (8 to 10 drops of blood) directly into a paediatric EDTA tube. They then recap and shake the tube to prevent clotting. The sample is stable for four days and can be sent back to the laboratory for testing by post or courier if at distance, and by collection within SWLP locations.

What are the advantages of capillary blood testing at SWLP?

Capillary blood testing (CBT) is less invasive and requires smaller amounts of blood than venous sampling by phlebotomy.. Samples can easily be taken in the community and sample quality is retained by additives in the sample tube. The sample remains liquid and retains the ability to offer quantitative results for infectious disease pathogen monitoring. Due to the UKAS-accredited dilutional techniques involved, multiple tests can be carried out on a single CBT sample which includes antibodies, antigens and either DNA or RNA testing on the same capillary blood sample.

Currently, we are testing CBT samples for:

  • HIV 1&2 antibody/p24 antigenHCV antibody
  • HBsAg
  • HB core total antibody
  • treponemal antibody (for syphilis testing)
  • HCV RNA viral load

HCV RNA positive samples are tested for HCV genotype.. Other nucleic acid tests, eg HBV DNA viral load or HIV RNA viral load can be substituted for HCV RNA viral load if preferred. Although antibody and antigen results are relatively unaffected by the dilutional techniques employed the lower limit of detection of HCV, HIV and HBV for viral load tests is 225 iu/ml and lower limit of quantification is 300 iu/ml.

The combination of both serological and molecular testing from one sample, on fully automated and verified equipment and assays, means that a further confirmatory test is usually unnecessary. The turnaround time for the test is four working days. Single target testing for HIV or HCV of HBV or syphilis screening can be accommodated on request.

Find out more

If you are interested in finding out more about this test or partnering with SWLP please email SWLPBusinessDevelopment@stgeorges.nhs.uk.

Latest news

July 1, 2022

Refurbished Immunology and ED laboratories at St George’s Hospital get official opening

This week, the newly refurbished Immunology and Emergency Department (ED) laboratories at St George’s Hospital were officially opened by Trust Managing Director Kate Slemeck and Chief Operating Officer Anne Brierley. A ribbon cutting was held at each laboratory and Kate and Anne were given a tour around the refurbished spaces by laboratory staff. The Immunology […]

Read more
June 24, 2022

HIV service at Croydon Hospital wins ‘Top Global Winner’ at the UNIVANTS awards

This week, it was announced that work to improve HIV outcomes at Croydon Hospital was awarded ‘Top Global Winner’ at the UNIVANTS 2021 awards. The work focused on the introduction of ‘opt-out’ HIV testing in the Emergency Department at Croydon Hospital, with a sustained rate of 97% over 18 months, setting an international gold standard. […]

Read more
June 20, 2022

Immunology services across south west London to be centralised at the Immunology Laboratory at St George’s Hospital

All Immunology services and tests are moving to the South West London Pathology (SWLP) Immunology Laboratory and Protein Reference Unit at St George’s Hospital, which will become the hub for immunology across south west London. Already one of the largest immunology services in the country, the team will be expanded further when immunology services and […]

Read more
May 16, 2022

Point of Care Testing (POCT) at St George’s gets first UKAS accreditation

Last month, the SWLP POCT team received the exciting news that after two years of hard work, the blood gas and glucose meter service at St George’s was given full UKAS accreditation. It is the largest and most complex POCT service in the country to receive full accreditation, which proved challenging for both the POCT […]

Read more